| SPPS peptide synthesis capacity | 16000 L |
|---|
BSE filing, NSE: LAURUSLABS. Summary written from the filing by ALFA Finder's alert engine.
Laurus Labs Ltd: key numbers
- Share price
- ₹2,170.00
- Market cap
- ₹1,17,248 Cr
- Revenue (annual)
- ₹6,813 Cr
- Net profit (annual)
- ₹888.8 Cr
- P/E (TTM)
- 107.2×Sector 46.1×
- Promoter holding
- 27.47%+0.00% QoQ
- FII holding
- 30.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laurus Labs Ltd
All →Laurus Labs Investor Presentation: Key Takeaways
Q2/H1 FY27: H1 revenue ₹4,233 Cr (+31%), EBITDA ₹1,406 Cr (33.2% margin), PAT ₹809 Cr (+126%). CDMO-led growth; ₹3,000 Cr+ capex planned FY27-28.
Laurus Labs Dividend
Laurus Labs approved a Re. 1.00 per share interim dividend for FY 2026-27. Record date is November 6, 2026; payment on or after November 19, 2026.
Laurus Labs Management Change
Laurus Labs appointed Mr. Kundan Kumar Jha as Joint Company Secretary effective November 1, 2026, following Board approval. The KMP appointment advances the company's succession planning process.
Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Laurus Labs Q2 FY27 Results: Net Profit ₹436.2 Cr, Up 124.3% YoY
Laurus Labs Ltd reported revenue from operations of ₹2,206 Cr (+33.4% YoY) and net profit of ₹436.2 Cr (+124.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹436.2 Cr · +124.3% YoY
Other results update announcements
All →Blue Star Results Update
Blue Star's Q2FY27 consolidated revenue rose 21% to Rs 2,930.95 crore, with operating profit up 10.5%. The press release highlights margin pressure from material cost increases.
NIIT Learning Systems Results Update
NIIT Learning reported Q2 FY27 revenue of Rs. 528.6 Crore, up 11.1%, and PAT of Rs. 37.3 Crore. Bluewater acquisition and a large contract were also flagged.
Thyrocare Technologies Results Update
Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.
Garware Technical Fibres Results Update
Garware Technical Fibres reported Q2FY27 consolidated PAT of Rs. 58.6 Crore, up 83.1%. The release carries results highlights only, with no new business event.
Godrej Consumer Products Results Update
Godrej Consumer Products reported Q2 FY27 consolidated revenue growth of 19% YoY and net profit of ₹523 crore. EBITDA grew 12% with double-digit volume growth across geographies.
P N Gadgil Jewellers Results Update
P N Gadgil Jewellers reported Q2 FY27 revenue of ₹2,666 Cr with 52.7% PAT growth. Same-store sales grew 25.5%; the company operates 80 stores.